prednisone has been researched along with Eosinophilia-Myalgia Syndrome in 8 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Eosinophilia-Myalgia Syndrome: A complex systemic syndrome with inflammatory and autoimmune components that affect the skin, fascia, muscle, nerve, blood vessels, lung, and heart. Diagnostic features generally include EOSINOPHILIA, myalgia severe enough to limit usual activities of daily living, and the absence of coexisting infectious, autoimmune or other conditions that may induce eosinophilia. Biopsy of affected tissue reveals a microangiopathy associated with diffuse inflammation involving connective tissue. (From Spitzer et al., J Rheumatol Suppl 1996 Oct;46:73-9; Blackburn WD, Semin Arthritis Rheum 1997 Jun;26(6):788-93)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We have studied a patient with recurrent bouts of angioedema, myalgia, and eosinophilia that was not due to L-tryptophan ingestion." | 3.68 | Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor. ( Bochner, BS; Friedman, B; Krishnaswami, G; Kroegel, C; Lichtenstein, LM; Schleimer, RP, 1991) |
| "Prednisone was reported to be helpful in 79% of patients who received it during the acute phase of the syndrome." | 1.29 | The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset. ( Clauw, DJ; Espinoza, LR; Hertzman, PA; Kaufman, LD; Mease, P; Pincus, T; Silver, RM; Thacker, HL; Varga, J, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Margolin, L | 1 |
| Puszczewicz, M | 1 |
| Zimmermann-Górska, I | 1 |
| Pietrzak-Kaczmarek, H | 1 |
| Lazowski, S | 1 |
| Hertzman, PA | 1 |
| Clauw, DJ | 1 |
| Kaufman, LD | 1 |
| Varga, J | 2 |
| Silver, RM | 1 |
| Thacker, HL | 1 |
| Mease, P | 1 |
| Espinoza, LR | 1 |
| Pincus, T | 1 |
| Moreaud, O | 1 |
| Mezin, P | 1 |
| De Saint Victor, JF | 1 |
| Noelle, B | 1 |
| Berger, F | 1 |
| Pellat, J | 1 |
| McKinley, KL | 1 |
| Harati, Y | 1 |
| Schneider, LW | 1 |
| Maul, GG | 1 |
| Jimenez, SA | 1 |
| Esper, JJ | 1 |
| Nigro, MA | 1 |
| Wishnow, R | 1 |
| Barnett, T | 1 |
| Perrotta, AL | 1 |
| Richardson, W | 1 |
| Bochner, BS | 1 |
| Friedman, B | 1 |
| Krishnaswami, G | 1 |
| Schleimer, RP | 1 |
| Lichtenstein, LM | 1 |
| Kroegel, C | 1 |
8 other studies available for prednisone and Eosinophilia-Myalgia Syndrome
| Article | Year |
|---|---|
Non-L-tryptophan related eosinophilia-myalgia syndrome with hypoproteinemia and hypoalbuminemia.
Topics: Anti-Inflammatory Agents; Edema; Eosinophilia-Myalgia Syndrome; Female; Humans; Hypoalbuminemia; Mid | 2003 |
[Diagnostic problems in eosinophilic fasciitis].
Topics: Adult; Biopsy; Chronic Disease; Diagnosis, Differential; Eosinophilia; Eosinophilia-Myalgia Syndrome | 2006 |
The eosinophilia-myalgia syndrome: status of 205 patients and results of treatment 2 years after onset.
Topics: Adult; Aged; Aged, 80 and over; Cognition Disorders; Eosinophilia-Myalgia Syndrome; Female; Follow-U | 1995 |
[Peripheral neuropathy unmasked by therapy with adrenal cortex hormones during myalgia-eosinophilia syndrome related to L-tryptophan].
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Humans; Immunoglobulins, Intravenous; Peripheral Nervo | 1994 |
Chronic immune activation in the eosinophilia-myalgia syndrome.
Topics: Adult; Aged; Aged, 80 and over; Eosinophilia-Myalgia Syndrome; Female; Humans; Immune System; Male; | 1993 |
Autoantibodies to nuclear lamin C in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.
Topics: Administration, Oral; Adult; Antibodies, Antinuclear; Autoantibodies; Cell Nucleus; Eosinophilia-Mya | 1992 |
Clinical improvement of the myopathy in eosinophilia-myalgia syndrome with steroids and rehabilitative therapy.
Topics: Adult; Eosinophilia-Myalgia Syndrome; Female; Humans; Methylprednisolone; Prednisone | 1992 |
Episodic eosinophilia-myalgia-like syndrome in a patient without L-tryptophan use: association with eosinophil activation and increased serum levels of granulocyte-macrophage colony-stimulating factor.
Topics: Angioedema; Eosinophilia-Myalgia Syndrome; Eosinophils; Flow Cytometry; Granulocyte-Macrophage Colon | 1991 |